A retrospective epidemiological study of screening-derived solid cancer incidence proxy rates in South Korea before and after COVID-19 using Korean National Health Insurance Service data
Aggregate South Korean national screening data show pandemic-era temporal associations with heterogeneous changes in selected solid cancer program proxy rates, which support an indirect screening-disruption and ascertainment interpretation rather than causal proof of a direct COVID-19 effect on solid cancer incidence.